Multi-cancer analysis reveals universal association of oncogenic LBH expression with DNA hypomethylation and WNT-Integrin signaling pathways

Young IC, Brabletz T, Lindley LE, Abreu M, Nagathihalli N, Zaika A, Briegel KJ (2023)

Publication Type: Journal article

Publication year: 2023

Journal

Cancer Gene Therapy Nature Publishing Group: Open Access Hybrid Model Option B

DOI: 10.1038/s41417-023-00633-y

Abstract

Limb-Bud and Heart (LBH) is a developmental transcription co-factor deregulated in cancer, with reported oncogenic and tumor suppressive effects. However, LBH expression in most cancer types remains unknown, impeding understanding of its mechanistic function Here, we performed systematic bioinformatic and TMA analysis for LBH in >20 different cancer types. LBH was overexpressed in most cancers compared to normal tissues (>1.5-fold; p < 0.05), including colon-rectal, pancreatic, esophageal, liver, stomach, bladder, kidney, prostate, testicular, brain, head & neck cancers, and sarcoma, correlating with poor prognosis. The cancer types showing LBH downregulation were lung, melanoma, ovarian, cervical, and uterine cancer, while both LBH over- and under-expression were observed in hematopoietic malignancies. In cancers with LBH overexpression, the LBH locus was frequently hypomethylated, identifying DNA hypomethylation as a potential mechanism for LBH dysregulation. Pathway analysis identified a universal, prognostically significant correlation between LBH overexpression and the WNT-Integrin signaling pathways. Validation of the clinical association of LBH with WNT activation in gastrointestinal cancer cell lines, and in colorectal patient samples by IHC uncovered that LBH is specifically expressed in tumor cells with nuclear beta-catenin at the invasive front. Collectively, these data reveal a high degree of LBH dysregulation in cancer and establish LBH as pan-cancer biomarker for detecting WNT hyperactivation in clinical specimens.

Involved external institutions

University of Miami US United States (USA) (US) Sylvester Comprehensive Cancer Center US United States (USA) (US)

How to cite

APA:

Young, I.C., Brabletz, T., Lindley, L.E., Abreu, M., Nagathihalli, N., Zaika, A., & Briegel, K.J. (2023). Multi-cancer analysis reveals universal association of oncogenic LBH expression with DNA hypomethylation and WNT-Integrin signaling pathways. Cancer Gene Therapy. https://dx.doi.org/10.1038/s41417-023-00633-y

MLA:

Young, In Chi, et al. "Multi-cancer analysis reveals universal association of oncogenic LBH expression with DNA hypomethylation and WNT-Integrin signaling pathways." Cancer Gene Therapy (2023).

BibTeX: Download